DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3.
Yang, Rachel L
DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3. [electronic resource] - Journal of translational medicine Oct 2015 - 335 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1479-5876
10.1186/s12967-015-0698-3 doi
Breast Neoplasms--genetics
Carcinoma, Intraductal, Noninfiltrating--genetics
Female
Genes, BRCA1
Genes, BRCA2
Genetic Carrier Screening
Humans
Mutation
Phenotype
Receptor Protein-Tyrosine Kinases--genetics
Receptor, ErbB-3--genetics
DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3. [electronic resource] - Journal of translational medicine Oct 2015 - 335 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1479-5876
10.1186/s12967-015-0698-3 doi
Breast Neoplasms--genetics
Carcinoma, Intraductal, Noninfiltrating--genetics
Female
Genes, BRCA1
Genes, BRCA2
Genetic Carrier Screening
Humans
Mutation
Phenotype
Receptor Protein-Tyrosine Kinases--genetics
Receptor, ErbB-3--genetics